Adult surgical patients
Conditions
Interventions
Remimazolam Tosilate:None
Sponsors
Xiangya Hospital Central South University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients receiving Remimazolam Tosilate injection for the maintenance of general anesthesia in non-cardiac surgery; 2.Patients aged >=18 years old, and with an ASA classification of <=3; 3.Patients must sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients who are participating in or planning to participate in any interventional clinical trials; 2.Patients who are allergic to any components of benzodiazepines or Remimazolam Tosilate; 3.Patients with severe depressive states, schizophrenia, or myasthenia gravis; 4.Patients who are expected to require postoperative admission to the ICU or continuous mechanical ventilation; 5.Patients whom the investigator deems unsuitable for this study for any other reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of Adverse Events (AEs) during the PACU period: The composite endpoint consists of emergence nausea and vomiting, emergence hypoxemia, and emergence hypotension; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Emergence Nausea and Vomiting;Time to meet discharge criteria;Incidence of Emergence Hypoxemia;Incidence of nausea and vomiting within 24 hours after surgery;QoR-15 scores on postoperative day 1 and day 3;Time of extubation;Incidence of Emergence Delirium and Postoperative Delirium;Incidence of Emergence Hypotension;Anesthesia Recovery Time;Incidence of Hypotension During Anesthesia Maintenance; | — |
Countries
China
Contacts
Public ContactE Wang
Xiangya Hospital Central South University
Outcome results
None listed